» Articles » PMID: 33251196

A Custom Ultra-Low-Cost 3D Bioprinter Supports Cell Growth and Differentiation

Abstract

Advances in 3D bioprinting have allowed the use of stem cells along with biomaterials and growth factors toward novel tissue engineering approaches. However, the cost of these systems along with their consumables is currently extremely high, limiting their applicability. To address this, we converted a 3D printer into an open source 3D bioprinter and produced a customized bioink based on accessible alginate/gelatin precursors, leading to a cost-effective solution. The bioprinter's resolution, including line width, spreading ratio and extrusion uniformity measurements, along with the rheological properties of the bioinks were analyzed, revealing high bioprinting accuracy within the printability window. Following the bioprinting process, cell survival and proliferation were validated on HeLa Kyoto and HEK293T cell lines. In addition, we isolated and 3D bioprinted postnatal neural stem cell progenitors derived from the mouse subventricular zone as well as mesenchymal stem cells derived from mouse bone marrow. Our results suggest that our low-cost 3D bioprinter can support cell proliferation and differentiation of two different types of primary stem cell populations, indicating that it can be used as a reliable tool for developing efficient research models for stem cell research and tissue engineering.

Citing Articles

Extrusion bioprinting: meeting the promise of human tissue biofabrication?.

Holland I Prog Biomed Eng (Bristol). 2025; 7(2).

PMID: 39904058 PMC: 11894458. DOI: 10.1088/2516-1091/adb254.


A Low-Cost, Open-Source 3D Printer for Multimaterial and High-Throughput Direct Ink Writing of Soft and Living Materials.

Weiss J, Mermin-Bunnell A, Solberg F, Tam T, Rosalia L, Sharir A Adv Mater. 2025; 37(10):e2414971.

PMID: 39748617 PMC: 11899504. DOI: 10.1002/adma.202414971.


Injectable and 3D-Printable Semi-Interpenetrating Polymer Networks Based on Modified Sodium Alginate for Cell Spheroid Formation.

Saravanou S, Samouilidou T, Tsitsilianis C, Taraviras S, Pasparakis G Biomacromolecules. 2024; 26(1):567-578.

PMID: 39734257 PMC: 11733927. DOI: 10.1021/acs.biomac.4c01343.


The cutting-edge progress in bioprinting for biomedicine: principles, applications, and future perspectives.

Liu S, Chen Y, Wang Z, Liu M, Zhao Y, Tan Y MedComm (2020). 2024; 5(10):e753.

PMID: 39314888 PMC: 11417428. DOI: 10.1002/mco2.753.


Biomaterials for extrusion-based bioprinting and biomedical applications.

Rossi A, Pescara T, Gambelli A, Gaggia F, Asthana A, Perrier Q Front Bioeng Biotechnol. 2024; 12:1393641.

PMID: 38974655 PMC: 11225062. DOI: 10.3389/fbioe.2024.1393641.


References
1.
Stathopoulou A, Roukos V, Petropoulou C, Kotsantis P, Karantzelis N, Nishitani H . Cdt1 is differentially targeted for degradation by anticancer chemotherapeutic drugs. PLoS One. 2012; 7(3):e34621. PMC: 3316709. DOI: 10.1371/journal.pone.0034621. View

2.
Galarraga J, Kwon M, Burdick J . 3D bioprinting via an in situ crosslinking technique towards engineering cartilage tissue. Sci Rep. 2019; 9(1):19987. PMC: 6934815. DOI: 10.1038/s41598-019-56117-3. View

3.
Zhao Y, Li Y, Mao S, Sun W, Yao R . The influence of printing parameters on cell survival rate and printability in microextrusion-based 3D cell printing technology. Biofabrication. 2015; 7(4):045002. DOI: 10.1088/1758-5090/7/4/045002. View

4.
Tsaniras S, Villiou M, Giannou A, Nikou S, Petropoulos M, Pateras I . Geminin ablation in vivo enhances tumorigenesis through increased genomic instability. J Pathol. 2018; 246(2):134-140. DOI: 10.1002/path.5128. View

5.
Li M, Tian X, Schreyer D, Chen X . Effect of needle geometry on flow rate and cell damage in the dispensing-based biofabrication process. Biotechnol Prog. 2012; 27(6):1777-84. DOI: 10.1002/btpr.679. View